BioNTech SE (BNTX) Inventory (2018 - 2026)

BioNTech SE has reported Inventory for 8 years, with the latest figure at $128.9 million in Q4 2025.

• Quarterly Inventory fell 57.43% year-over-year to $128.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $128.9 million (down 57.43% YoY) and the FY2025 annual result came in at $125.1 million, down 58.69% from the prior year.
• Inventory slipped to $128.9 million in Q4 2025 per BNTX's latest filing, from $263.9 million in the prior quarter.
• Over five years, Inventory peaked at $574.8 million in Q4 2021 and troughed at $128.9 million in Q4 2025.
• A 5-year average of $360.3 million and a median of $370.7 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2021 and 2025: Inventory soared 652.16% in 2021, then sank 57.43% in 2025.
• Over 5 years, Inventory stood at $574.8 million in 2021, then retreated by 21.98% to $448.5 million in 2022, then decreased by 14.19% to $384.9 million in 2023, then dropped by 21.34% to $302.7 million in 2024, then tumbled by 57.43% to $128.9 million in 2025.
• According to Business Quant data, Inventory over the past three periods registered $128.9 million, $263.9 million, and $261.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.